Skip to content

Clinical trials

Observational Myelodysplastic Syndromes trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Observational Country / region: Germany Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20073
20083
20103
20142
20171
20191
20211
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status4
Not yet recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene3
Bristol-Myers Squibb2
University Hospital Freiburg2
Charlotte Niemeyer, MD1
European Working Group of MDS in Childhood1
Gruppo Italiano Malattie EMatologiche dell'Adulto1
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH1
Istituto Clinico Humanitas1
Kiadis Pharma1
Radboud University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes16
Leukemia, Myeloid, Acute2
beta-Thalassemia2
Anemia1
Anemia, Aplastic1
Dyskeratosis Congenita1
Fanconi Anemia1
Graft vs Host Disease1
Hematologic Neoplasms1
Leukemia1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.